Quick Answer
Pacira BioSciences, Inc. reported Research And Development Expense of $117.31 million for the year ending 2025.
- Pacira BioSciences, Inc. showed an increase of +43.8% in Research And Development Expense from 2024 to 2025.
- This data is from Pacira BioSciences, Inc.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 17 years of available data (2009 to 2025), Pacira BioSciences, Inc.'s Research And Development Expense has grown by 347.2%.
- Historical annual values: Fiscal year 2025: $117.31 million | Fiscal year 2024: $81.58 million | Fiscal year 2023: $76.26 million | Fiscal year 2022: $84.80 million | Fiscal year 2021: $55.55 million | Fiscal year 2020: $59.42 million | Fiscal year 2019: $72.12 million | Fiscal year 2018: $55.69 million | Fiscal year 2017: $57.29 million | Fiscal year 2016: $45.68 million | Fiscal year 2015: $28.66 million | Fiscal year 2014: $18.73 million | Fiscal year 2013: $21.56 million | Fiscal year 2012: $9.94 million | Fiscal year 2011: $14.87 million | Fiscal year 2010: $18.63 million | Fiscal year 2009: $26.23 million.
- Data sourced from SEC EDGAR public filings as of June 21, 2026.
Last verified: